After decades of procedures and millions upon millions of implant recipients, the FDA has formalized procedures that, among other things, now require patient notification of the potential risks and complications that come with breast augmentation surgery.
The move comes after several cases of breast implant-associated large cell lymphoma were reported in primarily European markets. Initially thought to be tied to the textured implants used mostly by European doctors, ...
continue reading...The Mayo Clinic and the American Society of Plastic Surgeons have both published information about a rare cancer with possible ties to breast implants as concerns continue to grow over breast implant-associated anaplastic large cell lymphoma, or BIA-ALCL.
Initially, BIA-ALCL was thought to be a mostly European concern as the condition was generally associated with women who had received textured rather than smoothly surfaced ...
continue reading...After millions upon millions of procedures performed over the span of several decades, the safety of the implants used in breast augmentation and reconstructive surgeries have been thrust to the forefront of thought for both the medical community and the women who underwent the operations. For most women exploring the idea of implants in the late-20th to early-21st centuries, concerns over the procedure were limited to ...
Investigations into the growing body of evidence indicating a link between breast implants and a certain type of breast cancer are showing a troubling common thread: a complete lack of warning for the patient over the danger.
Numbers seem to support the notion that the decision to receive breast implants is made without much; if any, concern over personal health. 75 percent of the 400,000 breast implant procedures ...
continue reading...
A growing number of women are being diagnosed with a form of breast cancer linked to breast implants, and the calls for lawsuits and legislative action or regulation are rising.
16 deaths may already be associated with the condition known as BIA-ALCL or breast-implant associated anaplastic large cell lymphoma. U.S. diagnoses of the cancer are now up to 457 from a previous high of 414. ...
continue reading...The long-term safety of breast implants; a topic widely thought to have been resolved over the decades, is receiving renewed interest from medical communities around the world and is now on the radar of the U.S. Food and Drug Administration. What started as concern over a type of cancer predominantly tied to textured breast implants has led to new questions being ...
